Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Birnbaum

Showing results (71-80 of 232) with videos related to

Pageof 24
Sort By:
Pain Medicine (Malden, Mass.)|February 18, 2014
Duloxetine use in employees with low back pain: treatment patterns and direct and indirect costsJasmina I Ivanova, Howard G Birnbaum, Evan Kantor, et al.
Health Affairs (Project Hope)|December 7, 2020
Measuring The Impact Of Air Pollution On Health Care CostsHoward G Birnbaum, Christopher D Carley, Urvi Desai, et al.
Epilepsia|December 17, 2009
Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United StatesJasmina I Ivanova, Howard G Birnbaum, Yohanne Kidolezi, et al.
Pharmacoeconomics|April 21, 2010
Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the USCrystal Pike, Howard G Birnbaum, Matt Schiller, et al.
Journal of Agricultural Safety and Health|October 5, 2002
Fluorescent tracer evaluation of chemical protective clothing during pesticide applications in central Florida citrus grovesR A Fenske, S G Birnbaum, M M Methner, et al.
Current Medical Research and Opinion|September 14, 2006
Development of a COPD severity scoreE Q Wu, H G Birnbaum, M Cifaldi, et al.
Nature Neuroscience|February 6, 2007
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memorySusheel Vijayraghavan, Min Wang, Shari G Birnbaum, et al.
Journal of Medical Economics|July 23, 2014
Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladderJasmina I Ivanova, Eleanor Hayes-Larson, Rachael A Sorg, et al.
Pharmacoeconomics|July 14, 2010
Economic burden of epilepsy among the privately insured in the USJasmina I Ivanova, Howard G Birnbaum, Yohanne Kidolezi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2003
Attention-deficit/hyperactivity disorder: increased costs for patients and their familiesAndrine R Swensen, Howard G Birnbaum, Kristina Secnik, et al.
Pageof 24

Showing results (71-80 of 232) with videos related to

Sort By:
Pageof 24
Pain Medicine (Malden, Mass.)|February 18, 2014
Duloxetine use in employees with low back pain: treatment patterns and direct and indirect costsJasmina I Ivanova, Howard G Birnbaum, Evan Kantor, et al.
Health Affairs (Project Hope)|December 7, 2020
Measuring The Impact Of Air Pollution On Health Care CostsHoward G Birnbaum, Christopher D Carley, Urvi Desai, et al.
Epilepsia|December 17, 2009
Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United StatesJasmina I Ivanova, Howard G Birnbaum, Yohanne Kidolezi, et al.
Pharmacoeconomics|April 21, 2010
Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the USCrystal Pike, Howard G Birnbaum, Matt Schiller, et al.
Journal of Agricultural Safety and Health|October 5, 2002
Fluorescent tracer evaluation of chemical protective clothing during pesticide applications in central Florida citrus grovesR A Fenske, S G Birnbaum, M M Methner, et al.
Current Medical Research and Opinion|September 14, 2006
Development of a COPD severity scoreE Q Wu, H G Birnbaum, M Cifaldi, et al.
Nature Neuroscience|February 6, 2007
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memorySusheel Vijayraghavan, Min Wang, Shari G Birnbaum, et al.
Journal of Medical Economics|July 23, 2014
Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladderJasmina I Ivanova, Eleanor Hayes-Larson, Rachael A Sorg, et al.
Pharmacoeconomics|July 14, 2010
Economic burden of epilepsy among the privately insured in the USJasmina I Ivanova, Howard G Birnbaum, Yohanne Kidolezi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2003
Attention-deficit/hyperactivity disorder: increased costs for patients and their familiesAndrine R Swensen, Howard G Birnbaum, Kristina Secnik, et al.
Pageof 24